Search by Drug Name or NDC
NDC 55566-1050-01 ADSTILADRIN 3E+11 {VP}/mL Details
ADSTILADRIN 3E+11 {VP}/mL
ADSTILADRIN is a INTRAVESICAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ferring Pharmaceuticals. The primary component is NADOFARAGENE FIRADENOVEC.
MedlinePlus Drug Summary
Nadofaragene firadenovec-vncg is used to treat a certain type of bladder cancer that was not effectively treated with another medication (Bacillus Calmette-Guerin; BCG therapy). Nadofaragene firadenovec-vncg is in a class of medications called gene therapy. It works by helping your body to produce interferon alfa-2b, a natural substance that fights cancer cells in your bladder.
Related Packages: 55566-1050-01Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Nadofaragene firadenovec-vncg Intravesical
Product Information
| NDC | 55566-1050 |
|---|---|
| Product ID | 55566-1050_2f8eba64-9c7c-4d88-be10-6c0db8409e25 |
| Associated GPIs | |
| GCN Sequence Number | 084204 |
| GCN Sequence Number Description | nadofaragene firadenovec-vncg VIAL 3X10E11/ML INTRAVESIC |
| HIC3 | V5E |
| HIC3 Description | ANTINEOPLASTIC - GENE THERAPY AGENTS |
| GCN | 53398 |
| HICL Sequence Number | 048536 |
| HICL Sequence Number Description | NADOFARAGENE FIRADENOVEC-VNCG |
| Brand/Generic | Brand |
| Proprietary Name | ADSTILADRIN |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | nadofaragene firadenovec-vncg |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | INTRAVESICAL |
| Active Ingredient Strength | 3E+11 |
| Active Ingredient Units | {VP}/mL |
| Substance Name | NADOFARAGENE FIRADENOVEC |
| Labeler Name | Ferring Pharmaceuticals |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125700 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55566-1050-01 (55566105001)
| NDC Package Code | 55566-1050-1 |
|---|---|
| Billing NDC | 55566105001 |
| Package | 4 VIAL in 1 CARTON (55566-1050-1) / 20 mL in 1 VIAL |
| Marketing Start Date | 2023-07-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |